Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Pathophysiol. Nov 15, 2013; 4(4): 91-93
Published online Nov 15, 2013. doi: 10.4291/wjgp.v4.i4.91
Published online Nov 15, 2013. doi: 10.4291/wjgp.v4.i4.91
Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disorders
Richard Kellermayer, Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030-2399, United States
Author contributions: Richard Kellermayer wrote the manuscript.
Correspondence to: Dr. Richard Kellermayer, MD, PhD, Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Texas Children's Hospital, 6621 Fannin St., CC1010.00, Houston, TX 77030-2399, United States. kellerma@bcm.edu
Telephone: +1-713-7980319 Fax: +1-832-8253633
Received: April 30, 2013
Revised: July 23, 2013
Accepted: August 8, 2013
Published online: November 15, 2013
Processing time: 198 Days and 11 Hours
Revised: July 23, 2013
Accepted: August 8, 2013
Published online: November 15, 2013
Processing time: 198 Days and 11 Hours
Core Tip
Core tip: This review provides a focused overview of fecal bacteriotherapy and discusses possible mechanisms of action for this unconventional treatment. It also highlights the challenges, which this therapy faces.